A China-Australia seminar on the internationalization of biomedicine clinical research and development took place at Zhangjiang Pharma Valley in Pudong New Area, Shanghai recently.
A sound innovation and entrepreneurship ecosystem, active investment environment and favorable policies have made Shanghai Zhangjiang Hi-Tech Park a hot spot for startups.
One of the main forces of the pharmaceutical industry in Shanghai, the biomedicine industry in Pudong New Area has become a key industry in this area with a rapid growth in industrial scale.
Shanghai announced plans to roll out an upgraded mechanism on science and technology management in order to strengthen its innovative capacity at a news conference of the municipal government on March 20.
An immune-metabolic research center jointly launched by Shanghai Jiao Tong University and Yale University officially started construction in Shanghai on March 23.
The Optical Society of America recently announced the winner of the 2019 R.W. Wood Prize. Pan Jianwei, professor from the University of Science and Technology of China, won the prize.
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd recently announced the establishment of a wholly-owned subsidiary, Shanghai Zhangjiang Hi-Tech Zhihuixin Industrial Development Co Ltd.
The signing ceremony for the China-Thailand Joint Research Institute of Natural Medicine was held at Shanghai University of Traditional Chinese Medicine on March 20.